Compare GXO Logistics Inc (GXO) vs Twist Bioscience Corp (TWST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GXO Logistics Inc vs Twist Bioscience Corp — how do they compare? GXO Logistics Inc trades at $46.56 (market cap $5.32B), while Twist Bioscience Corp trades at $159.78 (market cap $10.08B). The key difference: Twist Bioscience Corp is the larger of the two by market cap, and Twist Bioscience Corp is trading nearer its 52-week high, GXO Logistics Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold GXO Logistics Inc for 28 Days and Twist Bioscience Corp for 27 Days on average.
| GXO | TWST | |
|---|---|---|
Market Cap | $5.32B | $10.08B |
Volume | 1,255,816 | 4,229,037 |
Sector | Industrials | Health |
52-Week High | $65.59 | $205.00 |
52-Week Low | $44.17 | $25.45 |
Typical Hold Time | 28 Days | 27 Days |
Enterprise Value | $10.67B | $10.01B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GXO Logistics trades at $46.36, up 0.8% with neutral technical indicators. The company shows improving fundamentals with three consecutive quarterly EPS beats and strong analyst support (88.9% buy ratings). Recent strategic partnerships with Columbia Sportswear and aerospace/defense expansion signal growth potential, though margins remain thin with net income at 0.96%.
GXO presents a compelling growth story with 42% upside to consensus price target of $66.67. Key catalysts include logistics industry recovery and operational efficiency initiatives, but investors face margin pressure risks and competitive threats in the contract logistics space that could limit profitability expansion.
Twist Bioscience (TWST) trades at $152.05, down 2.31% today but remains near recent highs following a significant rally driven by AI partnerships and strong sector interest. The company shows improving revenue growth ($377M in 2025) but continues to post substantial losses (-$78M net income). Technical indicators show mixed signals with bullish overall sentiment but bearish moving averages, while analyst consensus remains positive with 73% buy ratings.
TWST presents a high-risk, high-reward opportunity with strong growth potential through AI-driven drug discovery partnerships but faces significant execution risks amid persistent profitability challenges. The stock's valuation appears stretched given current fundamentals, requiring successful commercialization of pipeline assets to justify premium multiples.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GXO Logistics Inc
GXO is the world's largest pure-play contract logistics provider. It offers cutting-edge supply chain solutions, including automated warehousing and fulfillment, for global blue-chip companies.
Read more on GXO →About Twist Bioscience Corp
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →
